abstract:Anacor Pharmaceuticals (NASDAQ: ANAC) is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. It is based in Palo Alto, California, United States.
ThroughHCandANACOR, this paper intends to give acleardefinitionof theemployees'demandlevelsand their key demand, and suggestsvariousincentivesbased on differentincomelevels.
One drug Glaxo is testing in early human trials is licensed from biotech company Anacor Pharmaceuticals and uses a new type of chemistry based on the element boron.
Other risky bets include a drug that aims to prevent heart attacks by combating artery inflammation, and a partnership with Anacor, a San Francisco company that makes drugs based on a new type of chemistry involving the element boron.